View in EDS

Correction: Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia.

Saved in:
Bibliographic Details
Title: Correction: Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia.
Authors: Carratt SA; Oregon Health & Science University, Portland, OR, USA., Braun TP; Oregon Health & Science University, Portland, OR, USA., Coblentz C; Oregon Health & Science University, Portland, OR, USA., Schonrock Z; Oregon Health & Science University, Portland, OR, USA., Callahan R; Oregon Health & Science University, Portland, OR, USA., Curtiss BM; Oregon Health & Science University, Portland, OR, USA., Maloney L; Oregon Health & Science University, Portland, OR, USA., Foley AC; Oregon Health & Science University, Portland, OR, USA., Maxson JE; Oregon Health & Science University, Portland, OR, USA. maxsonj@ohsu.edu.
Source: Leukemia [Leukemia] 2022 Aug; Vol. 36 (8), pp. 2149.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35794242
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Correction: Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Carratt+SA%22">Carratt SA</searchLink>; Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Braun+TP%22">Braun TP</searchLink>; Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Coblentz+C%22">Coblentz C</searchLink>; Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Schonrock+Z%22">Schonrock Z</searchLink>; Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Callahan+R%22">Callahan R</searchLink>; Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Curtiss+BM%22">Curtiss BM</searchLink>; Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Maloney+L%22">Maloney L</searchLink>; Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Foley+AC%22">Foley AC</searchLink>; Oregon Health & Science University, Portland, OR, USA.<br /><searchLink fieldCode="AU" term="%22Maxson+JE%22">Maxson JE</searchLink>; Oregon Health & Science University, Portland, OR, USA. maxsonj@ohsu.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228704895%22">Leukemia</searchLink> [Leukemia] 2022 Aug; Vol. 36 (8), pp. 2149.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%2C+Specialist+Journals%22">Nature Publishing Group, Specialist Journals </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8704895 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5551 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208876924%22">08876924 </searchLink><i>NLM ISO Abbreviation: </i>Leukemia <i>Subsets: </i>MEDLINE; PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35794242
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41375-022-01646-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2149
    Titles:
      – TitleFull: Correction: Mutant SETBP1 enhances NRAS-driven MAPK pathway activation to promote aggressive leukemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Carratt SA
      – PersonEntity:
          Name:
            NameFull: Braun TP
      – PersonEntity:
          Name:
            NameFull: Coblentz C
      – PersonEntity:
          Name:
            NameFull: Schonrock Z
      – PersonEntity:
          Name:
            NameFull: Callahan R
      – PersonEntity:
          Name:
            NameFull: Curtiss BM
      – PersonEntity:
          Name:
            NameFull: Maloney L
      – PersonEntity:
          Name:
            NameFull: Foley AC
      – PersonEntity:
          Name:
            NameFull: Maxson JE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2022 Aug
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1476-5551
          Numbering:
            – Type: volume
              Value: 36
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Leukemia
              Type: main
ResultId 1